Yersu Kapran

Yersu Kapran

Auto-generated profile, based on publicly available information

Yersu Kapran

Department of Pathology, Koç University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
EAErman Aytaç
Erman Aytaç
LOLeyla ÖzEr
Leyla ÖzEr
BBBilgi Baca
Bilgi Baca
EBEmre BALIK
Emre BALIK
YKYersu Kapran
Yersu Kapran
TKTayfun KarahasanoğlU
Tayfun KarahasanoğlU
Colorectal cancer is the third most common cancer in Turkey. The current guidelines do not provide sufficient information to cover all aspects of the management of rectal cancer. Although treatment has been standardized in terms of the basic principles of neoadjuvant, surgical, and adjuvant therapy, uncertainties in the management of rectal cancer may lead to significant differences in clinical practice. In order to clarify these uncertainties, a consensus program was constructed with the participation of the physicians from the Acıbadem Mehmet Ali Aydınlar and Koç Universities. This program included the physicians from the departments of general surgery, gastroenterology, pathology, radiology, nuclear medicine, medical oncology, radiation oncology, and medical genetics. The gray zones in the management of rectal cancer were determined by reviewing the evidence-based data and current guidelines before the meeting. Topics to be discussed consisted of diagnosis, staging, surgical treatment for the primary disease, use of neoadjuvant and adjuvant treatment, management of recurrent disease, screening, follow-up, and genetic counseling. All those topics were discussed under supervision of a presenter and a chair with active participation of related physicians. The consensus text was structured by centralizing the decisions based on the existing data. Cite this article as: Aytaç E, Özer L, Baca B, et al. Optimizing the personalized care for the management of rectal cancer: A consensus statement. Turk J Gastroenterol. 2022;33(8):627-663.

1 January 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
HSHavva Sezer
Havva Sezer
MDMehmet Onur Demirkol
Mehmet Onur Demirkol
DYDilek Yazici
Dilek Yazici
YKYersu Kapran
Yersu Kapran
FAFaruk Alagöl
Faruk Alagöl
Background/aim: The aim of this study is to investigate clinicopathologic features of familial papillary thyroid carcinoma (fPTC) and compare them with sporadic papillary thyroid carcinoma (sPTC) in Turkish patients. A retrospective analysis of the papillary thyroid carcinoma (PTC) cases, with or without family history with a follow-up around 10 years was performed. Materials and methods: A series of patients with fPTC (82 fPTC families with 116 affected individuals) were compared with patients with sPTC (n = 112). The clinicopathologic features [(age, gender, histologic subtype, tumour size, bilaterally, multifocality, extrathyroidal extension (FEE), lymph node metastasis (LNM)I and treatment procedures (lymph node dissection, radioactive iodine ablation), and the outcomes like recurrences in the neck region, distant metastasis, and the need for reoperation were compared between the groups. Results: Vhen the groups were compared, there was no significant difference in age (P = 0.449), and tumour size (P 0.898) between familial and sporadic PTC patients. 0,TC group had a significantly higher risk of male gender (P = 0.001), bilaterally (P =0.004), multilocality (P 0.011), LNM (P = 0.013), PTE (P = 0.040), and distant metastasis (P < 0.0001) than the sPTC group. However, recurrence rate was similar between the 2 groups (13 = 0A36). Conclusion: The results of this study confirms a inure aggressive nature in fPTC patients, in terms of bilaterally, nuiltifocality, ETE, LNM, and distant metastasis, compared to sPTC patients in Turkish population.

13 June 2023 in The American Surgeon™
Verified
Journal Article
Closed access
HSHavva Sezer
Havva Sezer
DYDilek Yazıcı
Dilek Yazıcı
TTTarık Terzioğlu
Tarık Terzioğlu
STSerdar Tezelman
Serdar Tezelman
HCHande Bulut Canbaz
Hande Bulut Canbaz
FAFaruk Alagöl
Faruk Alagöl
Aim: The aims of the study are to evaluate the predictive value of early post-operative stimulated thyroglobulin (sTg) analysis on the recurrence risk, and to define a cut-off value that is related to recurrence risk in low to intermediate risk papillary thyroid cancer (PTC). Methods: This retrospective cohort study included individuals who were diagnosed with PTC aged 18 years or older and had been operated by experienced surgeons of a tertiary university hospital between the years 2011 and 2021. The American Thyroid Association thyroid cancer guidelines version 2015 was used as the risk stratification system. Early sTg measurement obtained at 3-4 weeks after surgery when TSH >30 µIU/mL. Data was collected from the hospital database. A total of 328 patients who had post-operative early sTg values with negative anti-Tg antibodies were included. Results: The median age was 44 years. Of the 328 patients, 223 (68%) were women. The median tumor diameter was 11 mm. One hundred ninety-one patients (58.2%) had low risk and 137 (41.8%) had intermediate risk for recurrent disease. Of the 328 patients, 4.0% had recurrent disease. In multivariate Cox regression, post-operative early sTg value [OR: 1.070 (1.038-1.116), P = .000], and the pre-operative malign cytology [OR: 1.483 (1.080-2.245), P = .042] were independent risk factors for recurrence. On the ROC curve analysis, the cut-off value of early sTg was 4.1 ng/mL for those with recurrent disease. Conclusion: This study demonstrated that early sTg could predict recurrent disease in patients with low to intermediate risk PTC. A cut-off of 4.1 ng/mL was identified with a high negative predictive value.

14 May 2019 in Bezmialem Science
Verified
Journal Article
Closed access
CECumhur Gokhan Ekmekci
Cumhur Gokhan Ekmekci
MGMine Güllüoğlu
Mine Güllüoğlu
YKYersu Kapran
Yersu Kapran
FDFerhunde Di̇zdaroğlu
Ferhunde Di̇zdaroğlu
UÖUğur Özbek
Uğur Özbek

21 March 2022 in Turkish Journal of Colorectal Disease
Verified
Journal Article
Closed access
IÖİlker Özgür
İlker Özgür
CKCemil Burak Kulle
Cemil Burak Kulle
MKMetin Keskin
Metin Keskin
HBHALİL ALPER BOZKURT
HALİL ALPER BOZKURT
MBMelek Bayram
Melek Bayram
MBMehmet Türker Bulut
Mehmet Türker Bulut